The California Supreme Court has agreed to take up a lower court decision which held an insurer didn’t have to pay to defend a drug company from claims related to the opioid epidemic.
The state’s high court on Wednesday indicated it granted a petition to review in Traveler’s Property Casualty Company of America v. Actavis, a case where the Fourth District Court of Appeal held late last year that Hartford, Connecticut-based Travelers didn’t have a duty to defend or indemnify Watson Pharmaceuticals in lawsuits filed by two California counties and the city of Chicago.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
